NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)

NCT03342690

CompletedN/A

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions: Chronic Heart Failure

Interventions: Eplerenone

Countries: Japan

Secondary Data Collection Study; Safety And Effectiveness Of Selara Under Japanese Medical Practice

Eligibility overview

Sex: ALL

Age: 0 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients in whom treatment with this drug is for CHF. The indications at approval for this drug are as follows. When using this drug, refer to the latest package insert of this drug.

Exclusion Criteria:

* Patients who were previously registered for this study. Patients who received eplerenone within the past three months regardless of the reason for use.

Locations (1)

Tokyo, Japan